Nu-Med Plus (NUMD) Change in Accured Expenses (2012 - 2025)
Nu-Med Plus (NUMD) reported Change in Accured Expenses of $2625.0 for Q4 2025, up 212.47% on a YoY basis from $840.09 in Q4 2024, and up 38.82% sequentially from $1891.0 in Q3 2025.
Nu-Med Plus (NUMD) Change in Accured Expenses (2012 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 14 years of Change in Accured Expenses data on file, last reported at $2625.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses rose 212.47% year-over-year to $2625.0; the trailing twelve-month figure through Dec 2025 stood at $3290.0 (down 62.27% YoY), and the FY2025 full-year result was $3290.0, down 62.27% from the prior year.
- Change in Accured Expenses climbed to $2625.0 in Q4 2025, from $1891.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $62945.0 in Q4 2022 to a low of -$6254.0 in Q2 2025.
- A 5-year average of $9924.5 and a median of $4787.0 in 2024 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses jumped 596.76% in 2021 and plunged 285.24% in 2024, its largest moves.
- Tracing NUMD's Change in Accured Expenses over 5 years: stood at $21493.0 in 2021, then soared by 192.86% to $62945.0 in 2022, then plunged by 98.0% to $1260.0 in 2023, then sank by 285.24% to -$2334.0 in 2024, then surged by 212.47% to $2625.0 in 2025.
- Business Quant data shows NUMD's Change in Accured Expenses at $2625.0 in Q4 2025, $1891.0 in Q3 2025, and -$6254.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 2,625.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,625.00 |
| Dec 31, 2025 | 2,625.00 |
| Sep 30, 2025 | 1,891.00 |
| Sep 30, 2025 | 1,891.00 |
| Jun 30, 2025 | -6,254.00 |
| Jun 30, 2025 | -6,254.00 |
| Mar 31, 2025 | 5,028.00 |
| Mar 31, 2025 | 5,028.00 |
| Dec 31, 2024 | -2,334.00 |
| Dec 31, 2024 | -2,334.00 |
| Sep 30, 2024 | -2,040.00 |
| Sep 30, 2024 | -2,040.00 |
| Jun 30, 2024 | 4,546.00 |
| Jun 30, 2024 | 4,546.00 |
| Mar 31, 2024 | 8,547.00 |
| Mar 31, 2024 | 8,547.00 |
| Dec 31, 2023 | 1,260.00 |
| Dec 31, 2023 | 1,260.00 |
| Sep 30, 2023 | 1,261.00 |
| Sep 30, 2023 | 1,261.00 |